Search





Search





Markets
/
Stocks
/
inbs
/

Intelligent Bio Solutions Inc

INBS

Add to Watchlist

1.805USD

+0.230+14.60%

Close 07-31 16:00（ET）Quotes delayed by 15 min

3.61MMarket Cap

LossP/E TTM

Intelligent Bio Solutions Inc

1.805

+0.230+14.60%

Financial Summary Income Statement Balance Sheet Cash Flow Statement

Overview

Financials

Discussions

Analysis

Company

Financial Summary Income Statement Balance Sheet Cash Flow Statement

INBS Cash Flow Statement

You can access the annual and quarterly cash flow statements of Intelligent Bio Solutions Inc to evaluate its financial soundness and stability.

Quarterly

Quarterly+Annual

Quarterly

Annual

YOY

Hide blank rows

FY2026Q3

FY2026Q2

FY2026Q1

FY2025Q4

FY2025Q3

FY2025Q2

FY2025Q1

FY2024Q4

FY2024Q3

FY2024Q2

FY2024Q1

FY2023Q4

FY2023Q3

FY2023Q2

FY2023Q1

FY2022Q4

FY2022Q3

FY2022Q2

FY2022Q1

FY2021Q4

FY2021Q3

FY2020Q1

FY2019Q4

FY2019Q1

FY2018Q4

FY2017Q4

Operating cash flows (indirect method)

Cash flow from continuing operating activities

-57.17%-4.33M

32.57%-1.57M

-19.25%-2.85M

24.93%-2.21M

-12.62%-2.76M

18.97%-2.32M

-81.98%-2.39M

-403.82%-2.94M

2.85%-2.45M

-20.51%-2.87M

30.73%-1.31M

66.09%-584.34K

-761.82%-2.52M

-67.01%-2.38M

-2382.65%-1.89M

-2.40%-1.72M

95.26%-292.22K

---1.43M

--82.96K

---1.68M

---6.16M

97.46%-10.11K

-73.50%-3.97M

---398.82K

-1117.89%-2.29M

---188.11K

Net income from continuing operations

-12.51%-2.87M

-19.05%-2.69M

-11.14%-2.99M

-10.99%-3.10M

14.60%-2.55M

-14.19%-2.26M

-10.79%-2.69M

-4.64%-2.80M

52.98%-2.99M

-362.78%-1.98M

-100.35%-2.43M

-27.93%-2.67M

-372.57%-6.35M

87.67%-427.07K

15.56%-1.21M

-145.60%-2.09M

57.23%-1.34M

---3.46M

---1.44M

---850.23K

---3.14M

54.31%-764.83K

-68.50%-3.19M

---1.67M

-987.99%-1.89M

---173.73K

Operating gains losses

146.08%584.52K

-73.48%65.51K

115.08%519.69K

96.23%463.97K

-8.24%237.54K

6.74%247.05K

-2.41%241.62K

35.75%236.45K

-94.18%258.86K

-33.78%231.45K

--247.60K

--174.17K

--4.45M

--349.53K

----

Other non-cash items

-832.55%-391.92K

128.00%255.05K

435.05%193.39K

-15.36%112.48K

59.03%53.50K

252.97%111.86K

-129.04%-57.72K

212.78%132.89K

118.40%33.64K

90.56%-73.13K

159.67%198.78K

-150.77%-117.83K

28.89%-182.83K

-130.50%-774.31K

-1532.58%-333.13K

26116.93%232.07K

-1.37%-257.09K

--2.54M

--23.25K

---892.00

---253.62K

----

--0.00

----

Change in working capital

-236.21%-1.71M

267.92%736.95K

-636.17%-576.91K

157.38%304.21K

-1827.58%-507.75K

56.40%-438.87K

-109.73%-78.37K

-125.99%-530.18K

108.38%29.39K

20.34%-1.01M

332.44%805.47K

1434.72%2.04M

-126.78%-350.56K

-152.55%-1.26M

-123.14%-346.53K

115.98%132.90K

147.37%1.31M

---500.38K

--1.50M

---831.69K

---2.76M

-40.82%754.72K

-97.04%-789.76K

--1.28M

-2687.45%-400.81K

---14.38K

-Change in receivables

-72.20%-421.70K

-16.43%261.17K

17.24%-123.21K

-19.84%-83.65K

-152.28%-244.88K

2.57%312.50K

45.60%-148.87K

-3290.27%-69.80K

-1971.71%-97.07K

201.14%304.68K

---273.65K

--2.19K

--5.19K

---301.24K

----

-94886.09%-218.47K

----

---230.00

189.56%53.34K

--18.42K

-Change in inventory

-140.60%-7.22K

1.13%37.93K

-81.84%7.04K

-51.90%48.27K

-86.64%17.79K

71.46%37.51K

173.06%38.75K

137.10%100.37K

435.24%133.16K

162.24%21.88K

---53.03K

---270.52K

---39.72K

---35.15K

----

-Change in payables and accrued expense

-404.55%-722.40K

104.48%45.45K

-356.22%-567.11K

2165.02%3.13M

58.89%237.20K

45.12%-1.01M

-81.80%221.34K

-114.83%-151.67K

-50.21%149.29K

-50.80%-1.85M

9243.27%1.22M

32.64%1.02M

-37.20%299.84K

-243.21%-1.22M

97.91%-13.30K

655.37%770.87K

-34.91%477.45K

---356.78K

---635.57K

--102.05K

--733.57K

-23.70%973.18K

70.76%-132.81K

--1.28M

-1284.56%-454.15K

---32.80K

-Change in other current assets

-67.99%-426.38K

33.35%426.94K

199.95%149.14K

-4253.67%-455.62K

29.17%-253.81K

-41.05%320.16K

-707.76%-149.21K

-99.21%10.97K

41.93%-358.34K

84.55%543.10K

93.91%-18.47K

313.72%1.39M

-173.88%-617.11K

447.12%294.27K

-114.66%-303.39K

28.62%-652.05K

126.92%835.24K

---84.78K

--2.07M

---913.47K

---3.10M

----

-Change in other current liabilities

-4.71%-66.23K

104.86%6.88K

147.22%15.12K

-513.32%-2.27M

-21687.71%-63.25K

-6371.30%-141.79K

116.11%6.12K

-998637.84%-369.53K

-76.43%293.00

-22.17%2.26K

109.49%2.83K

-100.26%-37.00

-78.72%1.24K

555.76%2.90K

-451.25%-29.84K

286.52%14.08K

3127.62%5.84K

--443.00

--8.49K

--3.64K

--181.00

----

Cash from non-recurring investing activities

Cash from operating activities

-57.17%-4.33M

32.57%-1.57M

-19.25%-2.85M

24.93%-2.21M

-12.62%-2.76M

18.97%-2.32M

-81.98%-2.39M

-403.82%-2.94M

2.85%-2.45M

-20.51%-2.87M

30.73%-1.31M

66.09%-584.34K

-761.82%-2.52M

-67.01%-2.38M

-2382.65%-1.89M

-2.40%-1.72M

95.26%-292.22K

---1.43M

--82.96K

---1.68M

---6.16M

97.46%-10.11K

-73.50%-3.97M

---398.82K

-1117.89%-2.29M

---188.11K

Investing cash flow

Net cash from continuing investing activities

---12.90K

--28.07K

--70.40K

4218.89%231.84K

----

--5.37K

----

Capital expenditures

----

--68.23K

--70.40K

4218.89%231.84K

----

--5.37K

----

Net cash flow from disposal of fixed assets

---12.90K

--28.07K

--70.40K

4218.89%231.84K

----

--5.37K

----

Net cash flow from business transactions

----

---181.75K

--174.48K

---181.75K

----

Net cash flow from other investing activities

100.00%0.00

--0.00

114.40%23.32K

-663.90%-14.38K

84.23%-8.94K

----

---161.94K

476.25%2.55K

-91.75%-56.67K

100.00%0.00

99.62%-678.00

---29.55K

---474.89K

---703.01K

---177.21K

----

--0.00

Cash from non-current investing activities

Net cash flow from investing activities

189.69%12.90K

-214.17%-28.07K

---70.40K

-24.63%-208.52K

-663.90%-14.38K

84.23%-8.94K

----

7.95%-167.31K

-98.53%2.55K

73.18%-56.67K

100.00%0.00

74.15%-181.75K

198.08%173.80K

---211.30K

---474.89K

---703.01K

---177.21K

----

--0.00

Financing cash flow

Cash flow from continuous financing activities

214.27%10.44M

6.79%674.65K

8282.01%3.56M

11230.64%602.00K

-69.16%3.32M

-83.31%631.74K

--42.45K

-88.48%5.31K

526.97%10.77M

1252.86%3.79M

----

--46.11K

--1.72M

---328.41K

----

--0.00

-100.00%0.00

--0.00

--498.10K

7470.18%532.35K

270.80%4.08M

---7.22K

475.34%1.10M

--191.43K

Net cash flow from debt Issuance/repayment

----

--100.30K

---65.53K

---34.77K

----

100.00%0.00

----

-115.65%-131.82K

--842.18K

Net cash flow from common stock issuance/repurchase

-85.18%489.05K

3.42%674.65K

550.62%224.53K

--602.00K

35.07%3.30M

-51.40%652.37K

--34.51K

--0.00

-4.33%2.44M

--1.34M

----

--0.00

--2.55M

----

--0.00

----

--0.00

----

--660.45K

Net cash flow from preferred stock issuance/repurchase

----

1276.48%3.04M

----

--0.00

--220.58K

----

--0.00

--648.75K

166.97%4.35M

--0.00

--1.63M

----

Proceeds from issuance of warrants

--9.95M

--0.00

41890.57%3.33M

-100.00%0.00

--0.00

--7.94K

--5.31K

--1.65M

----

--0.00

---14.41K

----

--0.00

-100.00%0.00

----

--0.00

--498.10K

----

Net cash flow from other financing activities

-100.00%0.00

100.00%0.00

--0.00

----

-99.69%20.63K

96.52%-20.63K

----

100.00%0.00

965.25%6.67M

-18.51%-592.36K

----

---54.19K

---771.31K

---499.82K

----

--0.00

----

--0.00

-1511.55%-116.40K

32.91%-265.69K

---7.22K

69.80%-396.01K

---1.31M

Net cash from non-recurrent financing activities

Net cash from financing activities

214.27%10.44M

6.79%674.65K

8282.01%3.56M

11230.64%602.00K

-69.16%3.32M

-83.31%631.74K

--42.45K

-88.48%5.31K

526.97%10.77M

1252.86%3.79M

----

--46.11K

--1.72M

---328.41K

----

--0.00

-100.00%0.00

--0.00

--498.10K

7470.18%532.35K

270.80%4.08M

---7.22K

475.34%1.10M

--191.43K

Net cash flow

Beginning cash balance

-66.98%740.37K

-58.39%1.66M

-83.82%1.02M

-70.13%2.81M

100.38%2.24M

2040.24%3.99M

310.09%6.30M

312.07%9.40M

-61.57%1.12M

-96.75%186.40K

-81.34%1.54M

-78.80%2.28M

-73.98%2.91M

-54.45%5.74M

-34.48%8.24M

-24.58%10.76M

-43.70%11.19M

--12.61M

--12.57M

--14.26M

--19.88M

-52.69%197.94K

-92.55%78.58K

--418.42K

2009.17%1.05M

--50.00K

Current period cash flow changes

983.70%6.12M

47.36%-919.73K

127.66%640.20K

42.23%-1.79M

-93.18%564.90K

-287.35%-1.75M

-71.35%-2.31M

-316.17%-3.09M

1411.68%8.28M

132.94%932.60K

45.87%-1.35M

70.48%-743.30K

-45.25%-631.14K

-99.67%-2.83M

-7274.98%-2.50M

-49.16%-2.52M

92.26%-434.53K

---1.42M

--34.78K

---1.69M

---5.62M

226.96%516.37K

118.76%119.36K

---406.73K

-10651.08%-636.23K

--6.03K

Effect of exchange rate changes

-95.38%604.00

102.66%1.20K

-102.47%-743.00

132.63%29.27K

128.06%13.06K

-162.65%-45.28K

177.16%30.10K

153.96%12.58K

-1031.70%-46.55K

-19.37%72.27K

69.30%-39.01K

74.53%-23.32K

-111.79%-4.11K

1060.78%89.62K

-163.70%-127.05K

-1686.38%-91.57K

-22.61%34.90K

--7.72K

---48.18K

---5.13K

--45.10K

-761.67%-5.87K

-98.12%10.40K

---681.00

20268.90%553.42K

--2.72K

Ending cash balance

144.46%6.86M

-66.98%740.37K

-58.39%1.66M

-83.82%1.02M

-70.13%2.81M

100.38%2.24M

2040.24%3.99M

310.09%6.30M

312.07%9.40M

-61.57%1.12M

-96.75%186.40K

-81.34%1.54M

-78.80%2.28M

-73.98%2.91M

-54.45%5.74M

-34.48%8.24M

-24.58%10.76M

--11.19M

--12.61M

--12.57M

--14.26M

6010.41%714.31K

-52.69%197.94K

--11.69K

646.74%418.42K

--56.03K

Free cash flow

----

29.64%-1.64M

---2.92M

17.21%-2.44M

-12.62%-2.76M

18.97%-2.32M

----

-404.74%-2.95M

2.85%-2.45M

-20.51%-2.87M

30.73%-1.31M

66.09%-584.34K

-761.82%-2.52M

---2.38M

---1.89M

---1.72M

---292.22K

----

97.46%-10.11K

-73.50%-3.97M

---398.82K

-1117.89%-2.29M

---188.11K

Currency unit

--USD

Audit opinions

----

FAQs

What is operating cash flow?



Operating cash flow is the cash generated or used by a company's core business operations. It adjusts net income for non-cash items and working capital changes, such as depreciation, receivables, inventory, and payables. Strong operating cash flow can indicate that the business is converting sales and earnings into real cash.

How Much Operating Cash Flow Did Intelligent Bio Solutions Inc Generate?



Intelligent Bio Solutions Inc generated -9.68M in operating cash flow in fiscal 2025, reflecting cash generated from its core business operations.

How Did Intelligent Bio Solutions Inc's Operating Cash Flow Change Year Over Year?



Intelligent Bio Solutions Inc's operating cash flow increased by -1.10% year over year.

What is investing cash flow?



Investing cash flow shows cash used for or generated from investment-related activities, such as capital expenditures, purchases or sales of investments, acquisitions, and asset disposals. Negative investing cash flow is not always bad, because it can reflect spending on future growth, but investors should check whether those investments support long-term returns.

How Much Does Intelligent Bio Solutions Inc Spend on Capital Expenditures?



Intelligent Bio Solutions Inc spent 231.84K on capital expenditures in the most recent quarter。

What is financing cash flow?



Financing cash flow shows how a company raises capital or returns capital to investors and creditors. It can include debt issuance, debt repayment, share issuance, share repurchases, dividend payments, and lease financing. Positive financing cash flow may show new capital raised, while negative financing cash flow may reflect debt repayment, dividends, or buybacks.

How Has Intelligent Bio Solutions Inc's Financing Cash Flow Changed?



Intelligent Bio Solutions Inc used 4.60M in financing activities in the latest quarter.

What is free cash flow and why does it matter for INBS?



Free cash flow is the cash a company has left after funding the capital spending needed to maintain or grow the business. It is often used to assess financial flexibility, debt repayment capacity, dividend sustainability, buyback potential, and valuation quality. Investors should compare free cash flow with net income, revenue growth, and capital expenditures.

What was Intelligent Bio Solutions Inc’s free cash flow in the latest quarter?



Free cash flow was -9.91M reflecting a -3.47% change from the previous year.